Drug intelligence / Profile preview

Hyaluronic acid microcrystalline membrane

Development stage: Unknown
Lead developer: Baiyiyuan BioTech
Administration: Topical, Surgical

Overview

Hyaluronic acid microcrystalline membrane is a medical device and biomaterial developed by Baiyiyuan BioTech for use in wound repair, tissue reconstruction, and general wound care. Composed of hyaluronic acid, the membrane is designed to function as a biocompatible scaffold that supports endogenous tissue regeneration while maintaining a moist environment conducive to healing. It is applied topically or surgically depending on the clinical requirement. As a medical device, its primary mode of action is structural and physical rather than pharmacological, immunological, or metabolic.

Brand names: 玻尿酸微晶膜
Other names: Hyaluronic acid microcrystalline membrane

Beyond the preview

Go deeper on Hyaluronic acid microcrystalline membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyaluronic acid microcrystalline membrane.

Explore the full profile